Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 14Nasopharyngeal Carcinoma 8Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 2Locally Advanced Malignant Neoplasm 2Adenocarcinoma 2Thymoma 1Small Cell Lung Cancer Limited Stage 1Rectal Diseases 1Quality of Life 1Patients With Esophageal Cancer(â…¡-â…¢) 1Pathologic Complete Response 1Neoplasms, Glandular and Epithelial 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm Metastasis 1Neoadjuvant Chemotherapy 1Nasopharyngeal Neoplasms 1Lymphoma 1Lymphatic Metastasis 1Locally Advanced Rectal Cancer 1Locally Advanced Gastric Cancer 1

Interventions

dehydroftorafur 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Immune Checkpoint Inhibitors 1Fluorouracil 1Cisplatin 1Chemoradiotherapy 1Carboplatin 1Capecitabine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Anal Canal Carcinoma × Chemoradiotherapy × Clear all
NCT05374252 2022-05-16

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Unknown
102 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡